Russell Investments Group
UTMD icon

Russell Investments Group’s Utah Medical Products UTMD Stock Holding History

Russell Investments Group’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$195K Buy
3,148
+327
+12% +$20.6K ﹤0.01% 2858
2025
Q4 		$158K Sell
2,821
-1,236
-30% -$71.6K ﹤0.01% 2920
2025
Q3 		$255K Buy
4,057
+1,299
+47% +$76.8K ﹤0.01% 2722
2025
Q2 		$157K Buy
2,758
+2,334
+550% +$127K ﹤0.01% 2707
2025
Q1 		$23.8K Sell
424
-42,777
-99% -$2.56M ﹤0.01% 3069
2024
Q4 		$2.66M Sell
43,201
-7,265
-14% -$470K ﹤0.01% 1516
2024
Q3 		$3.38M Buy
50,466
+9,086
+22% +$617K ﹤0.01% 1405
2024
Q2 		$2.76M Sell
41,380
-456
-1% -$31K ﹤0.01% 1476
2024
Q1 		$2.97M Sell
41,836
-13,137
-24% -$985K ﹤0.01% 1433
2023
Q4 		$4.63M Sell
54,973
-3,666
-6% -$304K 0.01% 1162
2023
Q3 		$5.04M Sell
58,639
-9,032
-13% -$833K 0.01% 1077
2023
Q2 		$6.31M Sell
67,671
-1,817
-3% -$171K 0.01% 987
2023
Q1 		$6.59M Buy
69,488
+3,838
+6% +$353K 0.01% 974
2022
Q4 		$6.6M Sell
65,650
-6,072
-8% -$554K 0.01% 958
2022
Q3 		$6.12M Buy
71,722
+4,463
+7% +$394K 0.01% 957
2022
Q2 		$5.78M Sell
67,259
-14,399
-18% -$1.23M 0.01% 1029
2022
Q1 		$7.34M Buy
81,658
+3,160
+4% +$291K 0.01% 955
2021
Q4 		$7.85M Buy
78,498
+1,695
+2% +$173K 0.01% 1026
2021
Q3 		$7.13M Sell
76,803
-5,829
-7% -$515K 0.01% 1051
2021
Q2 		$7.03M Sell
82,632
-41,913
-34% -$3.63M 0.01% 1135
2021
Q1 		$10.8M Sell
124,545
-30,575
-20% -$2.69M 0.02% 897
2020
Q4 		$13.1M Sell
155,120
-6,847
-4% -$584K 0.03% 698
2020
Q3 		$12.9M Buy
161,967
+14,857
+10% +$1.23M 0.03% 644
2020
Q2 		$13M Buy
147,110
+10,138
+7% +$910K 0.03% 612
2020
Q1 		$12.9M Sell
136,972
-26,405
-16% -$2.45M 0.03% 552
2019
Q4 		$17.6M Buy
163,377
+16,579
+11% +$1.68M 0.03% 609
2019
Q3 		$14.1M Buy
146,798
+55,644
+61% +$5.17M 0.03% 685
2019
Q2 		$8.71M Buy
91,154
+42,249
+86% +$3.56M 0.02% 947
2019
Q1 		$4.32M Buy
48,905
+645
+1% +$56.7K 0.01% 1304
2018
Q4 		$4.01M Sell
48,260
-11,664
-19% -$1.03M 0.01% 1245
2018
Q3 		$5.64M Sell
59,924
-6,026
-9% -$576K 0.01% 1239
2018
Q2 		$7.27M Sell
65,950
-12,578
-16% -$1.31M 0.02% 1083
2018
Q1 		$7.76M Buy
78,528
+7,350
+10% +$656K 0.01% 1108
2017
Q4 		$5.63M Buy
71,178
+21,140
+42% +$1.65M 0.01% 1271
2017
Q3 		$3.68M Buy
50,038
+2,419
+5% +$174K 0.01% 1429
2017
Q2 		$3.45M Buy
47,619
+7,649
+19% +$503K 0.01% 1430
2017
Q1 		$2.49M Sell
39,970
-1,487
-4% -$93.6K ﹤0.01% 1636
2016
Q4 		$2.97M Buy
+41,457
New +$2.7M 0.01% 1581

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group's UTMD Position: Q1 2026 in Review

Russell Investments Group increased its Utah Medical Products (UTMD) stake by 12% in Q1 2026, buying an estimated $20.6K and bringing the position to 3,148 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #2858.

Russell Investments Group first reported a position in UTMD in Q4 2016 and has held it in 38 quarters since. The position peaked at $17.6M in Q4 2019. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Russell Investments Group held 3,148 shares of Utah Medical Products worth $195K as of Q1 2026.
  • Russell Investments Group bought 327 Utah Medical Products shares in Q1 2026, an estimated $20.6K.
  • Utah Medical Products made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2858 holding.
  • Russell Investments Group first reported a position in Utah Medical Products in Q4 2016 and has held it in 38 quarters since.
  • Russell Investments Group's Utah Medical Products position peaked at $17.6M in Q4 2019.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.